Hal V Barron is a WHHS alumnus, Class of 1981Of course there's an Eagle out there working on a COVID remedy!
Dr. Hal V Barron, WHHS Class of 1981
GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage Covid-19 patients, entering the race to find a winner in a promising class of antiviral drugs to combat the pandemic.
Hal Barron, GlaxoSmithKline’s chief scientific officer, and George Scangos, CEO of Vir Biotechnology, join “Squawk on the Street” to discuss.
Follow the link to listen to the broadcast: